Definitive Contract W9113M07C0159
Award Date 6/7/07
Potential Completion Date 8/29/19
Potential Value $42M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Incentive
Place of Performance
Columbia, MD 21046, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award from the Office of Land and Emergency Management, a civilian agency, is for the procurement of AUTO-INJECTORS FOR NERVE AGENT EXPOSURE. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. and a manufacturer of medical countermeasures, particularly autoinjector devices and nerve agent antidote treatments. The contract is a firm-fixed-price purchase order with a ceiling value of $27,529.20 and a completion date of May...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
- The U.S. Office of the Assistant Secretary for Administration awarded a $418,637.55 firm-fixed-price purchase order to Meridian Medical Technologies, LLC for DuoDote auto-injectors (FPAE NDC #11704-0620-01) with an ultimate completion date of January 5, 2026. The contract was designated as a Total Small Business set-aside, with performance to be executed in St. Louis, Missouri. Meridian Medical Technologies is a wholly-owned subsidiary of Pfizer Inc. specializing in the development and...
- This is a firm-fixed-price purchase order awarded by the U.S. Marshals Service Tactical Operations Division to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The $15,514.80 contract is for the delivery of auto-injectors containing the nerve agent antidotes atropine and pralidoxime. The contract does not utilize any set-aside designations. Meridian Medical Technologies is a key provider of auto-injector devices and nerve agent antidote treatments across the federal...
- The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Division of Strategic National Stockpile (SNS) awarded a $9,920,853.00 definitive firm-fixed-price contract to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., for the emergency procurement of 140,010 DuoDote Single Dose Autoinjectors. This contract was awarded without any set-aside designation. Meridian Medical Technologies is a global provider of...
- Meridian Medical Technologies, LLC, a Pfizer subsidiary, was awarded a delivery order valued at approximately $992.7K by the Bureau of Medical Services for DuoDote autoinjectors, with completion targeted for September 29, 2025. This firm-fixed-price contract, issued on September 30, 2024, carries no small business set-aside designation and will be performed in St. Louis, Missouri. DuoDote autoinjectors represent a critical medical countermeasure combining atropine and pralidoxime chloride for...
- On September 30, 2024, the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive firm-fixed-price contract to Meridian Medical Technologies, LLC for the supply of Atropine & Pralidoxime Chloride Injector single-dose auto-injectors (DuoDote) for the Strategic National Stockpile. The contract has a ceiling value of approximately $129.7 million with a one-year performance period from September 30, 2025 through...
- This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medical products and supplies to the U.S. government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract, valued at $7,851.30, is a delivery order under Amerisourcebergen's Indefinite Delivery...
- This federal contract award is for the delivery of 4,564,375 units of the epinephrine 0.3 mg auto-injector medical device, valued at $1,378.08. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This single-award IDC...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injector devices to the Department of Defense (DoD) and its agencies. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies. The contract, valued at $1,531.20, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense...